The Vanguard Group Discloses Stake in Spire Healthcare

The Vanguard Group, Inc. recently filed a Form 8.3 disclosing its interest in Spire Healthcare Group plc. According to the filing, Vanguard holds 14,359,721 shares, representing 3.57% of Spire Healthcare's ordinary shares. This disclosure, made under Rule 8.3 of the Takeover Code, reflects the firm's significant stake in Spire Healthcare as of November 27, 2025.

The document confirms the sale of 658 ordinary shares at 2.29 GBP per unit. No cash-settled or stock-settled derivative positions are reported in this disclosure, and there are no agreements or understandings relating to options or derivatives, as stated.

This public opening position disclosure underscores Vanguard Group’s investment strategy in the healthcare sector. With no other parties involved in the offer, the focus remains solely on Spire Healthcare Group plc. For further details, the contact person named is Shawn Acker.